Novartis Q3 Profit Reaches $1.2 Billion, Adjusted EPS Tops Wall Street Estimates

Novartis AG (NVS) reported third-quarter profit of $1.2 billion on Tuesday, with adjusted earnings of $2.46 per share beating the average analyst estimate of $2.25. Net income came to 63 cents per share for the Basel, Switzerland-based drugmaker. The adjusted figure excludes non-recurring costs. Revenue for the quarter totaled $14.52 billion, falling short of the $14.56 billion forecast by four analysts surveyed by Zacks Investment Research.